1. Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients;A, Jr, Medsger T.; T, Masi A.; P, Rodnan G.; G, Benedek T.; H, Robinson;Ann Intern Med,1971
2. Klinische Bedeutung der bronchoalveolaren Lavage bei progressiver systemischer Sklerodermie;Konig, G.; Luderschmidt, C.; P, Clocuh Y.; Scherer, U.; Fruhmann, G.;Dtsch Med Wochenschr,1982
3. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage;M, Silver R.; F, Metcalf J.; H, Stanley J.; C, LeRoy E.;Arthritis Rheum,1984
4. Steroid-responsive interstitial pulmonary disease in systemic sclerosis. Monitoring by bronchoalveolar lavage;M, Kallenberg C.G.; M, Jansen H.; D, Elema J.; H, The T.;Chest,1984
5. Role of inflammation in the lung disease of systemic sclerosis: Comparison with idiopathic pulmonary fibrosis;R, Owens G.; L, Paradis I.; S, Gryzan;7 Lab Clin Med,1986